Market Movers Archives | Page 316 of 871 | Smartkarma

Capital One Financial Corporation (COF)

179.30 USD +5.77 (+3.33%) Volume: 6.13M

Capital One Financial Corporation’s stock price soared to 179.30 USD, marking a significant trading session increase of +3.33%. With a robust trading volume of 6.13M and a year-to-date percentage change of +0.55%, COF continues to demonstrate promising financial performance in the market.

Latest developments on Capital One Financial Corporation

Capital One Financial Corp. stock experienced fluctuations today amidst signs of a potential deal with Discover Financial closing. Reports indicate that the spread between Discover Financial and Capital One has narrowed as the Department of Justice considers allowing the deal to proceed. Despite facing a class action claim for a data breach, Capital One’s stock outperformed competitors, with positive news also emerging for DuPont. Various institutional investors have been adjusting their positions in Capital One Financial Co. (NYSE:COF), with some selling shares while others acquiring more, reflecting differing outlooks on the company’s performance in the upcoming quarters.

A look at Capital One Financial Corporation Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Capital One Financial Corporation has a solid overall outlook according to Smartkarma Smart Scores. With a high Value score of 4, the company is seen as a strong investment option. While its Dividend score of 2 may not be as high, Capital One still maintains decent Growth, Resilience, and Momentum scores of 3 each. This indicates that the company is well-positioned for long-term success in the financial sector.

As a diversified bank with a presence in multiple states, Capital One Financial Corporation offers a wide range of financial products and services to various clients. The company’s strong Value score suggests that it is undervalued in the market, making it an attractive option for investors. Despite a lower Dividend score, Capital One’s Growth, Resilience, and Momentum scores all point towards a positive long-term outlook for the company, indicating stability and potential for continued success.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Charles River Laboratories International, Inc. (CRL)

150.52 USD -5.03 (-3.23%) Volume: 1.36M

Charles River Laboratories International, Inc.’s stock price currently stands at 150.52 USD, experiencing a dip of -3.23% this trading session with a trading volume of 1.36M, reflecting a YTD percentage change of -18.46%, indicating a challenging market performance for CRL.

Latest developments on Charles River Laboratories International, Inc.

Today, Charles River Laboratories International, Inc. (NYSE:CRL) saw fluctuations in its stock price as Mawer Investment Management Ltd. purchased 5,769 shares. Baird adjusted the price target for Charles River Laboratories International to $155 from $173 while maintaining a neutral rating. Additionally, Charles River and Valo Health’s Logica collaboration identified a new Lupus drug candidate, impacting the company’s stock outlook. Despite hitting a 52-week low at $150.19, the question remains whether Wall Street is bullish or bearish on Charles River Laboratories‘ future performance.

A look at Charles River Laboratories International, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

According to Smartkarma Smart Scores, Charles River Laboratories has a mixed long-term outlook. While the company scores high in momentum, indicating strong market performance, its scores for value, growth, resilience, and dividend are more moderate. This suggests that while Charles River Laboratories is currently showing positive momentum, investors may want to consider other factors before making long-term investment decisions.

Charles River Laboratories International, Inc. is a company that provides research tools and support services for drug discovery and development. They specialize in supplying animal research models for pharmaceutical and biotechnology companies, hospitals, and academic institutions. With a varied score across different factors, investors should carefully assess the overall outlook of the company before making any investment decisions.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Moderna, Inc. (MRNA)

28.35 USD -2.77 (-8.90%) Volume: 20.43M

Moderna, Inc.’s stock price currently stands at 28.35 USD, experiencing a significant dip of -8.90% this trading session, with an active trading volume of 20.43M. The biotechnology company’s stock has seen a downward trend YTD, marking a -31.82% decline, reflecting the volatile nature of the pharmaceutical market.

Latest developments on Moderna, Inc.

Moderna stock experienced a significant drop today following the resignation of FDA official Peter Marks, leading to a slide in biotech stocks. The departure of Marks, a key figure in vaccine regulation, raised concerns about regulatory risks for Moderna. Reports of his resignation prompted a selloff in vaccine stocks, including Moderna, Novavax, and Pfizer. The market reacted negatively to the news, causing Moderna’s stock price to plummet amidst uncertainty about the future of vaccine regulations. This shake-up comes as Moderna continues to face challenges in the market, with its stock hitting a 52-week low recently. Despite these setbacks, Moderna received approval from the Australian Therapeutic Goods Administration for its RSV vaccine for older adults, expanding its portfolio beyond COVID. Investors and analysts are closely monitoring Moderna’s movements as the company navigates through these regulatory challenges and market pressures.

Moderna, Inc. on Smartkarma

Analysts at Baptista Research have been closely covering Moderna Inc., providing insights into the company’s financial performance and strategic positioning. In a recent report titled “Moderna Inc.: Is Its mRNA Platform Fueling A Multi-Billion-Dollar Pipeline Beyond COVID?”, the analysts discussed the opportunities and challenges faced by Moderna. The company reported a total revenue of $3.2 billion for the year 2024, with a net loss of $3.6 billion. Despite a decrease in revenue from the previous year, the analysts lean bullish on Moderna’s potential.

Another report by Baptista Research titled “Moderna In Crisis? A Possible Wake-Up Call That Investors Have Been Dreading!” highlighted the transformation Moderna is undergoing post-pandemic. The analysts noted a shift in investor sentiment towards the company, following record-breaking Covid-19 vaccine sales. With updates in financial performance and strategic repositioning, Moderna faces significant headwinds but continues to expand its global presence for unmatched impact, as discussed in the report “Moderna Inc.: Expanding Global Presence For Unmatched Impact! – Major Drivers”.

A look at Moderna, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Moderna, Inc. is showing strong potential for long-term growth and value according to Smartkarma’s Smart Scores. With high scores in Value and Resilience, the biotechnology company is positioned well for success in the future. Moderna’s focus on developing messenger RNA therapeutics and vaccines for various diseases indicates a promising outlook for the company.

Although Moderna may not be a top choice for dividend investors with a low score in that category, its momentum and growth potential are still notable. The company’s emphasis on mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases aligns with current market trends and future healthcare needs. Overall, Moderna’s Smart Scores suggest a positive long-term outlook for the biotechnology company.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

lululemon athletica inc. (LULU)

283.06 USD -10.00 (-3.41%) Volume: 4.41M

lululemon athletica inc.’s stock price stands at 283.06 USD, experiencing a drop of -3.41% this trading session with a trading volume of 4.41M, and a notable decrease of -25.98% YTD, reflecting a challenging market performance.

Latest developments on lululemon athletica inc.

Lululemon Athletica has been making headlines recently with a series of events impacting its stock price. The company has been offering new products and events to attract cautious consumers, but despite strong earnings, shares dropped 13% in a week. The CEO has expressed concerns about unexpected customer behavior, leading to a decrease in guidance as wary consumers and trade worries grow. Analysts have reacted strongly to the weak 2025 outlook, causing a significant fall in share prices. Despite this, some investors are betting big on Lululemon’s future growth and strategic expansion, while others have been selling off their shares. With a mix of positive and negative news surrounding the company, Lululemon Athletica is facing challenges in balancing promising innovation with financial pressures amidst cautious consumer spending.

lululemon athletica inc. on Smartkarma

Analysts on Smartkarma have been closely monitoring the coverage of Lululemon Athletica, a popular athletic apparel company. According to MBI Deep Dives, Lululemon’s 4Q’24 update showed a shift in sentiment as the company’s double-digit revenue growth trend since its IPO in 2007 may be coming to an end, with a 5-7% growth guidance for 2025. On the other hand, Baptista Research remains bullish on Lululemon, highlighting the company’s international growth and market expansion as key drivers for its top-line growth. With revenue growing by 9% in the third quarter of fiscal 2024, particularly driven by strong performance in international markets like China, Lululemon continues to attract attention from investors.

MBI Deep Dives‘ analysis of Lululemon’s 3Q’24 update also sheds light on the market’s perception of the company. Despite facing skepticism throughout the year, Lululemon has seen its stock rise by almost 50% in the last three months, indicating a shift in sentiment. While the numbers for the third quarter may resemble the previous quarter, management’s positive outlook has contributed to a more upbeat tone surrounding the company. As analysts continue to track Lululemon’s performance and market dynamics, investors are keen to see how the company navigates future challenges and opportunities in the athletic apparel industry.

A look at lululemon athletica inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Lululemon Athletica shows a promising long-term outlook. With strong scores in Growth and Resilience, the company is positioned well for future expansion and able to withstand economic challenges. This indicates that Lululemon Athletica is likely to experience continued success and growth in the athletic clothing market.

Although Lululemon Athletica may not be the best choice for investors seeking dividends, its overall outlook remains positive. With a solid score in Value and Momentum, the company is showing potential for long-term value appreciation and sustained growth. As a global retailer of athletic clothing, Lululemon Athletica is well-positioned to continue serving customers worldwide with its range of fitness apparel.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Altria Group, Inc. (MO)

60.02 USD +1.87 (+3.22%) Volume: 17.33M

Altria Group, Inc.’s stock price has shown robust performance, currently trading at 60.02 USD, with an impressive trading session surge of +3.22%. The tobacco giant, demonstrating strong investor confidence, has seen a trading volume of 17.33M and a year-to-date percentage increase of +14.78%, indicating a positive market trend.

Latest developments on Altria Group, Inc.

Altria Group, Inc. (NYSE:MO) has seen its stock price hit a 52-week high at $59.71, driven by strong annual gains and the company’s appeal to institutional owners who hold 61% of the company. Despite recent rating downgrades and concerns about smoke-free ambitions being put on hold, analysts are highlighting Altria’s potential for over 9% stock price appreciation in 2025 on top of dividends. With Big Tobacco targeting Trump and the future of nicotine looking to be smoke-free, investors are debating whether Altria Group is a buy, sell, or hold in the coming years.

Altria Group, Inc. on Smartkarma

Analysts at Baptista Research provide bullish coverage on Altria Group, highlighting the company’s ability to thrive despite shrinking cigarette sales. In their research reports, they emphasize Altria’s strong financial performance, with a 3.4% growth in adjusted diluted earnings per share for the full year of 2024. The company’s focus on returning capital to shareholders through dividends and share repurchases has been a key factor contributing to its success.

Furthermore, Baptista Research delves into Altria Group‘s strategic expansion in the E-Vapor division, particularly through NJOY, as a critical growth lever. The analysts acknowledge the company’s efforts to navigate regulatory pressures and market dynamics while maintaining financial strength. They emphasize the importance of evaluating various factors that could impact the company’s stock price in the future, including regulatory landscapes and consumer preferences for reduced-risk products.

A look at Altria Group, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Altria Group, Inc. is showing a positive long-term outlook based on the Smartkarma Smart Scores. With top scores in Dividend, Growth, Resilience, and Momentum, the company seems to be in a strong position for the future. The high scores indicate that Altria Group is performing well in terms of its ability to generate income for investors, its potential for expansion, its ability to withstand market challenges, and its overall market performance.

As a holding company that manufactures and sells tobacco products, including cigarettes, cigars, and pipe tobacco, Altria Group also holds an interest in a brewery company. Despite facing regulatory challenges in the tobacco industry, the company’s strong performance across various factors suggests that it is well-positioned to navigate these challenges and continue to deliver value to its shareholders in the long run.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

The Interpublic Group of Companies, Inc. (IPG)

27.16 USD +0.87 (+3.31%) Volume: 17.02M

Explore the stock performance of The Interpublic Group of Companies, Inc. (IPG), currently trading at 27.16 USD, marking a positive surge of +3.31% this trading session. With a substantial trading volume of 17.02M and a slight YTD decrease of -3.07%, IPG’s stock price continues to capture the attention of investors.

Latest developments on The Interpublic Group of Companies, Inc.

Interpublic Group of Companies’ stock price experienced a strong trading day, outperforming its competitors in the market. This positive movement comes as Wall Street’s most accurate analysts have weighed in on three tech and telecom stocks with over 3% dividend yields. Investors are closely monitoring these developments as they anticipate further growth and potential opportunities in the company’s stock performance.

The Interpublic Group of Companies, Inc. on Smartkarma

Analysts on Smartkarma, such as Baptista Research, have been covering Interpublic Group Of Companies and providing insights on the company’s performance. In a recent report titled “Interpublic Group of Companies: Dealing With Challenges of Managing Agency Restructuring & Brand Overhaul! – Major Drivers”, Baptista Research highlighted the company’s stable yet complex performance during the Third Quarter of 2024. Despite market challenges, Interpublic Group reported flat organic growth year-over-year and a net revenue decrease of 2.9%. The company’s revenue before billable expenses also remained unchanged compared to the previous year.

A look at The Interpublic Group of Companies, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, the long-term outlook for Interpublic Group Of Companies appears to be positive overall. The company received high scores in Dividend and Momentum, indicating strong performance in these areas. Additionally, the company scored moderately in Value and Growth, showing potential for future growth and value. However, the company received a lower score in Resilience, suggesting some vulnerability in this aspect. Overall, Interpublic Group Of Companies seems to be well-positioned for success in the long run.

The Interpublic Group of Companies, Inc. is a global organization that consists of advertising agencies and marketing service companies. They offer a wide range of services including advertising, media buying, direct marketing, healthcare communications, and public relations. With a diverse portfolio of services, Interpublic Group Of Companies is able to cater to various client needs and maintain a strong presence in the competitive marketing industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Live Nation Entertainment, Inc. (LYV)

130.58 USD +5.55 (+4.44%) Volume: 7.95M

Live Nation Entertainment, Inc.’s stock price soars to 130.58 USD, marking an impressive 4.44% increase in the latest trading session, with a robust trading volume of 7.95M. The entertainment giant continues to show resilience in the stock market, posting a year-to-date percentage change of +0.83%, underscoring its potential as a solid investment choice.

Latest developments on Live Nation Entertainment, Inc.

Live Nation Entertainment Inc. (NYSE:LYV) experienced a strong trading day outperforming its competitors, with key stakeholders like Korea Investment CORP, Norges Bank, and Pictet Asset Management Holding SA making significant investments in the company. Meanwhile, companies like Mitsubishi UFJ Trust & Banking Corp and Corebridge Financial Inc. adjusted their stock holdings. Artisan Partners Limited Partnership and Keystone Investors PTE Ltd. also increased their stakes in Live Nation Entertainment, Inc. However, Prudential Financial Inc. and Sei Investments Co. sold off shares. Amidst these movements, the company faces potential challenges as President Trump plans an executive order targeting ticket scalping, as revealed in a recent document.

Live Nation Entertainment, Inc. on Smartkarma

Analysts at Baptista Research on Smartkarma have been closely following Live Nation Entertainment, Inc and have published two research reports on the company. The first report titled “Live Nation Entertainment: Is Its Sponsorship & Ancillary Revenue Optimization Giving Them An Edge?” leans bullish on the company’s outlook. It highlights Live Nation’s recent earnings performance, showcasing positive and negative aspects that could influence its future trajectory. The report notes a strong start to the year with high consumer demand driving up stadium show sell-through rates significantly.

In another report by Baptista Research, titled “Live Nation Entertainment: Food & Beverage Transformation As A Critical Growth Lever! – Major Drivers,” the analysts emphasize the company’s strong performance in the third quarter of 2024. The report delves into various segments of Live Nation’s operations, pointing out positive indicators and potential areas of concern that could impact its future performance. Specifically, the report highlights robust activity in Live Nation’s ticketing segment, Ticketmaster, with a notable 15% increase in sales reported in early October year-over-year.

A look at Live Nation Entertainment, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Live Nation Entertainment, Inc. has a promising long-term outlook based on its Smartkarma Smart Scores. With high scores in Growth and Momentum, the company is positioned for future success in the live entertainment industry. Its strong momentum indicates positive investor sentiment and potential for continued growth.

Although Live Nation Entertainment, Inc. may not score as high in Value and Dividend, its resilience score suggests that the company is well-equipped to weather challenges and adapt to changing market conditions. Overall, Live Nation Entertainment, Inc. appears to be a solid investment choice for those looking to capitalize on the growth of the live events industry.

### Live Nation Entertainment, Inc. produces live concerts and sells tickets to those events over the Internet. The Company also offers ticketing services for leading arenas, stadiums, professional sports franchises and leagues, college sports teams, performing arts venues, museums and theaters. ###

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Paramount Global (PARA)

11.96 USD +0.40 (+3.46%) Volume: 27.06M

Paramount Global’s stock price is currently valued at 11.96 USD, showcasing a positive trading session with a surge of +3.46%. With a trading volume of 27.06M and a year-to-date percentage change of +14.34%, Paramount Global (PARA) continues to exhibit promising stock price performance in the market.

Latest developments on Paramount Global

Paramount Global stock saw significant movements today following a series of key events. Jim Cramer recommended selling Paramount Global shares, prompting investors to take profits. Despite this, Paramount Global Cl B stock outperformed competitors on a strong trading day. Yahoo made headlines by hiring former Paramount executive Josh Line as their Chief Marketing Officer, while also announcing a partnership with Paramount for CPG measurement in TV advertising. Additionally, several investment firms made moves in Paramount Global stock, with IPG Investment Advisors decreasing their position and New Age Alpha Advisors buying shares. These developments have contributed to the fluctuating stock price of Paramount Global today.

A look at Paramount Global Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Paramount Global, a media company that produces and distributes entertainment content, has received a mix of Smart Scores across different factors. While scoring high in Value and Momentum, indicating a strong financial position and positive market sentiment, the company falls short in Growth. This suggests that while Paramount Global may be a solid investment in the short term, investors may need to consider the company’s long-term growth potential.

With average scores in Dividend and Resilience, Paramount Global shows stability in its dividend payouts and ability to weather economic downturns. However, with a lower score in Growth, the company may need to focus on expanding its offerings and capturing new markets to ensure sustained success in the future. Overall, Paramount Global‘s Smart Scores provide valuable insights into the company’s overall outlook and areas for potential improvement.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Biggest stock gainers today in S&P 500

Biggest stock losers today in S&P 500

What is Smartkarma SmartScore?

It is a compound score for a Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores (Value, Dividend, Growth, Resilience, Momentum scores) computed by Smartkarma.

The best stock screener – Smartkarma SmartScore Screener

Smartkarma’s stock screener, Smartkarma SmartScore Screener, allows you to easily discover undervalued gems, high dividend stocks, and high growth stocks, across multiple countries and sectors.

Explore the Smartkarma SmartScore Screener now.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

American International Group, Inc. (AIG)

86.94 USD +3.32 (+3.97%) Volume: 9.83M

American International Group, Inc.’s stock price is currently performing robustly at 86.94 USD, witnessing a healthy rise of +3.97% in this trading session with a trading volume of 9.83M. AIG’s stock has shown impressive resilience with a year-to-date increment of +19.42%, reflecting its strong market position and investor confidence.

Latest developments on American International Group, Inc.

American International Group Inc. (AIG) is set to report its first-quarter 2025 financial results on May 1, 2025, followed by a conference call on May 2, 2025. The company recently announced a $7.5 billion stock buyback plan, leading to a boost in its stock price. AIG also revealed plans to increase investments in private credit and set ambitious targets for 2025-27, which has garnered investor satisfaction. Despite facing trade secret theft allegations and trimming claims in unfair competition disputes, AIG remains focused on achieving key profitability targets under CEO Zaffino’s new plan. With positive stock performance and strategic moves in its investment portfolio, AIG continues to attract investor interest and maintain a strong position in the market.

American International Group, Inc. on Smartkarma

Analysts on Smartkarma are closely tracking American International Group (AIG) with a bullish sentiment. Value Investors Club highlights AIG’s repositioning in the insurance industry, showcasing a renewed growth strategy and improved financial performance. Baptista Research also provides insights on AIG, discussing the company’s transformation post-financial crisis under Peter Zafino’s leadership, focusing on specialty insurance for strong industry returns.

American Airlines Group Inc., a major player in the airline industry, is under scrutiny by analysts on Smartkarma. Baptista Research delves into American Airlines’ recent performance metrics, revenue milestones, and challenges in regaining corporate traveler trust. The research also highlights the company’s strategic adjustments aimed at improving future outcomes amidst operational disruptions. Business Breakdowns further discuss AIG’s rise, fall, and rebirth, emphasizing the company’s impressive transformation post-financial crisis and focus on profitability through divesting non-core businesses.

A look at American International Group, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

According to Smartkarma Smart Scores, American International Group has a positive long-term outlook. With a strong momentum score of 5, the company is showing promising growth potential. Additionally, AIG scores a 3 in value, dividend, growth, and resilience, indicating a well-rounded performance across these key factors. As an international insurance organization catering to a wide range of customers, AIG provides property-casualty insurance, life insurance, and retirement services.

Looking ahead, American International Group is positioned well for continued success in the insurance industry. With solid scores across various factors, including a high momentum score, AIG is expected to maintain its growth trajectory. As a company serving commercial, institutional, and individual customers, AIG’s diverse portfolio of insurance products and services is likely to contribute to its resilience and overall performance in the long term.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma